- Home
- ARVN vs CCSI Comparison
ARVN vs CCSI Comparison
Compare ARVN & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CCSI
- Stock Information
- Founded
- ARVN 2015
- CCSI 2021
- Country
- ARVN United States
- CCSI United States
- Employees
- ARVN N/A
- CCSI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- ARVN Health Care
- CCSI Technology
- Exchange
- ARVN Nasdaq
- CCSI Nasdaq
- Market Cap
- ARVN 438.1M
- CCSI 475.1M
- IPO Year
- ARVN 2018
- CCSI N/A
- Fundamental
- Price
- ARVN $9.12
- CCSI $18.94
- Analyst Decision
- ARVN Buy
- CCSI Hold
- Analyst Count
- ARVN 15
- CCSI 5
- Target Price
- ARVN $31.86
- CCSI $27.20
- AVG Volume (30 Days)
- ARVN 2.8M
- CCSI 146.4K
- Earning Date
- ARVN 05-06-2025
- CCSI 05-07-2025
- Dividend Yield
- ARVN N/A
- CCSI N/A
- EPS Growth
- ARVN N/A
- CCSI 17.26
- EPS
- ARVN N/A
- CCSI 4.62
- Revenue
- ARVN $263,399,999.00
- CCSI $350,382,000.00
- Revenue This Year
- ARVN N/A
- CCSI $1.26
- Revenue Next Year
- ARVN N/A
- CCSI $0.88
- P/E Ratio
- ARVN N/A
- CCSI $4.03
- Revenue Growth
- ARVN 235.54
- CCSI N/A
- 52 Week Low
- ARVN $5.94
- CCSI $11.62
- 52 Week High
- ARVN $37.38
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- ARVN 52.04
- CCSI 38.85
- Support Level
- ARVN $5.94
- CCSI $17.84
- Resistance Level
- ARVN $6.86
- CCSI $19.27
- Average True Range (ATR)
- ARVN 0.55
- CCSI 1.21
- MACD
- ARVN 0.58
- CCSI -0.02
- Stochastic Oscillator
- ARVN 93.47
- CCSI 30.43
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.